Title: Method of Treating Malignant Mesothelioma
Patent Number: 8,771,688
Filed: Feb. 7, 2012
Lead Inventor: Chikao Morimoto, University of Tokyo
Title: Method and Constructs for Delivering Double-stranded RNA to Pest Organisms
Patent Number: 8,772,254
Filed: Oct. 25, 2005
Lead Inventor: Thierry Bogaert, Devgen (Syngenta)
Title: Cell-transfecting Formulations of Small Interfering RNA-related Compositions and Methods of Making and Use
Patent Number: 8,772,255
Filed: March 21, 2008
Lead Inventor: Timothy Burkoth, Novartis Vaccines and Diagnostics
Title: Single-walled Carbon Nanotube/siRNA Complexes and Methods Related Thereto
Patent Number: 8,772,258
Filed: July 1, 2011
Lead Inventor: D. Lynn Kirkpatrick, Ensysce Biosciences
Title: Preventive or Therapeutic Agent for Fibrosis
Patent Number: 8,772,262
Filed: Oct. 14, 2011
Lead Inventor: Esteban Gabazza, Otsuka Pharmaceutical
Title: Synthetic Double-stranded Oligonucleotides for Specific Inhibiting on Gene Expression
Patent Number: 8,772,469
Filed: July 11, 2002
Lead Inventor: Eugen Uhlmann, Sanofi
Title: Compositions and Methods for Treatment of Prostate and Other Cancers
Patent Number: 8,772,470
Filed: Nov. 30, 2007
Lead Inventor: Martin Gleave, University of British Columbia
Title: Targeted Delivery of siRNA
Patent Number: 8,772,471
Filed: Jan. 25, 2008
Lead Inventor: Premlata Shankar, Immune Disease Institute (Harvard Medical School)
Title: siRNA Conjugate and Preparation Method Thereof
Patent Number: 8,772,472
Filed: Sept. 13, 2012
Lead Inventor: Bo Ram Han, Bioneer
Title: Methods and Materials for Conferring Resistance to Pests and Pathogens of Plants
Patent Number: 8,772,572
Filed: April 22, 2013
Inventor: Charles Niblett, Venganza